‘Dean of Asian Myeloma’ Dr. Kazuyuki Shimizu to Receive First Asian Myeloma Network (AMN) Distinguished Service Award
October 21, 2023 08:30 ET
|
International Myeloma Foundation
Dr. Kazuyuki Shimizu to Receive Inaugural Asian Myeloma Network Distinguished Service Award at IMF's 7th AMN Summit in Bangkok, Thailand on October 21, 202
IMF Medical Student Scholars for Health Equity in Myeloma Present Research at the 2023 NMA Annual Convention & Scientific Assembly
September 07, 2023 08:45 ET
|
International Myeloma Foundation
NEW ORLEANS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF), in partnership with the National Medical Association (NMA), the W. Montague Cobb Institute, and the...
The International Myeloma Foundation Welcomes Global Leader & Patient Advocate Emma Hatcher as Global VP of Patient Engagement & Advocacy
August 31, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) announced today that global leader and patient advocate Emma Hatcher has been named as the IMF’s Global...
The International Myeloma Foundation (IMF) Amplifies #kNOwMyeloma Campaign for Blood Cancer Awareness Month 2023
August 24, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, Aug. 24, 2023 (GLOBE NEWSWIRE) -- In 2010, the U.S. Congress designated September as Blood Cancer Awareness Month to create awareness, increase fundraising, and support patients...
The International Myeloma Foundation (IMF) Welcomes Visionary & Strategic Fundraiser Sylvia Dsouza as Vice President of Philanthropy
August 17, 2023 05:45 ET
|
International Myeloma Foundation
A Media Snippet accompanying this announcement is available by clicking the link or image above. LOS ANGELES, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF)...
Myeloma Support Group Leader Jack Aiello and Global Finance & Strategy Leader Sanjay Singh Elected to International Myeloma Foundation Board of Directors
July 27, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, July 27, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today welcomed two of its newest Board Members: Myeloma Support Group Leader and 28-year myeloma survivor...
World-Renowned Scientist, S. Vincent Rajkumar, MD, Appointed as Chairman-Elect of the Board of Directors of the International Myeloma Foundation (IMF)
July 20, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, July 20, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that world-renowned myeloma clinician and researcher S. Vincent Rajkumar, MD, has been...
International Myeloma Foundation (IMF) to Hold In-Person 2023 Patient and Family Seminar in Los Angeles in August
July 13, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, July 13, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that a 2023 IMF Patient and Family Seminar (PFS) will take place in-person from August 18-19...
The International Myeloma Foundation’s Nurse Leadership Board Launches Myeloma University
July 06, 2023 08:45 ET
|
International Myeloma Foundation
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation’s (IMF) Nurse Leadership Board (NLB) today announced the launch of Myeloma University—a FREE online educational...
Harpoon Therapeutics Announces Completion of Planned Patient Enrollment in Phase 1 Study of HPN217 in Relapsed/Refractory Multiple Myeloma
June 27, 2023 07:30 ET
|
Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced...